Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
After two years of dedicated and persistent advocacy by ADI, dementia will, for the first time, be formally recognised within the new UN Political Declaration on noncommunicable diseases (NCDs) and mental health, as a leading NCD.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
ADI hosted its first virtual regional meeting for ADI members in Latin America, since the COVID-19 pandemic began, on 12 November. The second virtual regional meeting Asia Pacific took place a week later on 12 November. During the Latin America meeting, 18 participants from 13 countries were in attendance. The 2-hour meeting…
The 'Building an inclusivity society' campaign from ADI member France Alzheimer aims to raise awareness amongst civil society and to dismantle stigmatic attitudes and ideas around dementia.
The news follows a negative vote trend by the Committee for Medicinal Products for Human Use (CHMP) at their oral explanation meeting.
In this blog, the co-leaders of the Brain Health Diplomacy Working Group from The Global Brain Health Institute (GBHI), write about the necessity for brain health diplomacy in advancing better brain health.
Raymond Xiong writes about his inspiration behind creating and sharing MECA exercises, which incorporate music, gymnastics and cognitive activity, to improve the wellbeing of people living with dementia.
The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.
World Alzheimers Month 2021 has just ended and marks the most successful awareness raising campaign to date in its decade long history.
Eisai’s lecanemab will represent the second anti-Amyloid Beta therapy to be evaluated by the FDA as a disease modifying treatment for early Alzheimer’s disease.